Kenneth A. Tassey Jr. Net Worth & Insider Trades

Kenneth A. Tassey Jr. - CEO, Boston Therapeutics, Inc

As of April 4, 2014

What is Kenneth A. Tassey Jr.'s Net Worth?

The current estimated net worth of Boston Therapeutics, Inc's CEO, Kenneth A. Tassey Jr., is estimated to be about $70.4K . Kenneth A. Tassey Jr. owns about 3,040,000 units of Boston Therapeutics, Inc common stock. In the last 2 years at Boston Therapeutics, Inc, Kenneth A. Tassey Jr. has sold an estimated value of $40K worth.

What is Kenneth A. Tassey Jr.'s Past Insider Trading?

Kenneth A. Tassey Jr.'s largest sale order was 160,000 units , worth over $40K on March 27, 2012. In total, Kenneth A. Tassey Jr. has made about 2 transactions over 2 years of their time at Boston Therapeutics, Inc. Kenneth A. Tassey Jr. usually trades in April and March, with the busiest year in 2012 and 2014.

Kenneth A. Tassey Jr.

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kenneth A. Tassey Jr.'s' Mailing Address?

  • Mailing address is 226 Karatzas Avenue #309 Manchester NH 03104 NH

What are Boston Therapeutics, Inc's Past Insider Trades?

Boston Therapeutics, Inc's most recent insider trade came on February 13, 2018 by Carl W Rausch who bought 0 unit worth $0 . In the last 6 years, insiders at Boston Therapeutics, Inc have sold an estimated value of $82.69K and bought an estimated value of $639.52K worth of shares. Insider trading is most common in January, with the busiest year in 2015. The most active traders at the company are David Platt, CEO and Chairman,  Anthony Squeglia, Chief Financial Officer,  and Dale H Conaway, Director .

Boston Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1